Advertisement

Index by author

September 01, 2015; Volume 354,Issue 3

  1. Knox, Ronald J.

    1. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity
      Martin A. Lewis, Lisa Hunihan, John Watson, Robert G. Gentles, Shuanghua Hu, Yazhong Huang, Joanne Bronson, John E. Macor, Brett R. Beno, Meredith Ferrante, Adam Hendricson, Ronald J. Knox, Thaddeus F. Molski, Yan Kong, Mary Ellen Cvijic, Kristin L. Rockwell, Michael R. Weed, Angela M. Cacace, Ryan S. Westphal, Andrew Alt and Jeffrey M. Brown
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 340-349; DOI: https://doi.org/10.1124/jpet.115.224071

  2. Kondoh, Masuo

    1. Claudin-1 Binder Enhances Epidermal Permeability in a Human Keratinocyte Model
      Misaki Nakajima, Shotaro Nagase, Manami Iida, Shuji Takeda, Mayo Yamashita, Akihiro Watari, Yoshitaka Shirasago, Masayoshi Fukasawa, Hiroyuki Takeda, Tatsuya Sawasaki, Kiyohito Yagi and Masuo Kondoh
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 440-447; DOI: https://doi.org/10.1124/jpet.115.225391

  3. Kong, Yan

    1. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity
      Martin A. Lewis, Lisa Hunihan, John Watson, Robert G. Gentles, Shuanghua Hu, Yazhong Huang, Joanne Bronson, John E. Macor, Brett R. Beno, Meredith Ferrante, Adam Hendricson, Ronald J. Knox, Thaddeus F. Molski, Yan Kong, Mary Ellen Cvijic, Kristin L. Rockwell, Michael R. Weed, Angela M. Cacace, Ryan S. Westphal, Andrew Alt and Jeffrey M. Brown
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 340-349; DOI: https://doi.org/10.1124/jpet.115.224071

  4. Koudriakova, Tatiana

    1. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
      Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Diane Nepomuceno, Steven Sutton, Leah Aluisio, Ian Fraser, Brian Lord, James Shoblock, Natalie Welty, Sandra R. Chaplan, Zuleima Aguilar, Robin Halter, Anthony Ndifor, Tatiana Koudriakova, Michele Rizzolio, Michael Letavic, Nicholas I. Carruthers, Timothy Lovenberg and Christine Dugovic
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 471-482; DOI: https://doi.org/10.1124/jpet.115.225466

  5. Kuriyama, Chiaki

    1. Intestinal Sodium Glucose Cotransporter 1 Inhibition Enhances Glucagon-Like Peptide-1 Secretion in Normal and Diabetic Rodents
      Takahiro Oguma, Keiko Nakayama, Chiaki Kuriyama, Yasuaki Matsushita, Kumiko Yoshida, Kumiko Hikida, Naoyuki Obokata, Minoru Tsuda-Tsukimoto, Akira Saito, Kenji Arakawa, Kiichiro Ueta and Masaharu Shiotani
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 279-289; DOI: https://doi.org/10.1124/jpet.115.225508

  6. Large, Charles H.

    1. A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons
      Marcelo D. Rosato-Siri, Erika Zambello, Chiara Mutinelli, Nicoletta Garbati, Roberto Benedetti, Laura Aldegheri, Francesca Graziani, Caterina Virginio, Giuseppe Alvaro and Charles H. Large
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 251-260; DOI: https://doi.org/10.1124/jpet.115.225748

  7. Lazenka, Matthew F.

    1. Role of Dopamine Type 1 Receptors and Dopamine- and cAMP-Regulated Phosphoprotein Mr 32 kDa in Δ9-Tetrahydrocannabinol–Mediated Induction of ΔFosB in the Mouse Forebrain
      Matthew F. Lazenka, Aaron J. Tomarchio, Aron H. Lichtman, Paul Greengard, Marc Flajolet, Dana E. Selley and Laura J. Sim-Selley
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 316-327; DOI: https://doi.org/10.1124/jpet.115.224428

  8. Lefever, Timothy W.

    1. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol–Like Effects in Mice
      Jenny L. Wiley, Julie A. Marusich, Timothy W. Lefever, Kateland R. Antonazzo, Michael T. Wallgren, Ricardo A. Cortes, Purvi R. Patel, Megan Grabenauer, Katherine N. Moore and Brian F. Thomas
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 328-339; DOI: https://doi.org/10.1124/jpet.115.225326

  9. Letavic, Michael

    1. Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
      Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Diane Nepomuceno, Steven Sutton, Leah Aluisio, Ian Fraser, Brian Lord, James Shoblock, Natalie Welty, Sandra R. Chaplan, Zuleima Aguilar, Robin Halter, Anthony Ndifor, Tatiana Koudriakova, Michele Rizzolio, Michael Letavic, Nicholas I. Carruthers, Timothy Lovenberg and Christine Dugovic
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 471-482; DOI: https://doi.org/10.1124/jpet.115.225466

  10. Lewis, Martin A.

    1. Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity
      Martin A. Lewis, Lisa Hunihan, John Watson, Robert G. Gentles, Shuanghua Hu, Yazhong Huang, Joanne Bronson, John E. Macor, Brett R. Beno, Meredith Ferrante, Adam Hendricson, Ronald J. Knox, Thaddeus F. Molski, Yan Kong, Mary Ellen Cvijic, Kristin L. Rockwell, Michael R. Weed, Angela M. Cacace, Ryan S. Westphal, Andrew Alt and Jeffrey M. Brown
      Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 340-349; DOI: https://doi.org/10.1124/jpet.115.224071
« Previous (Pages : 5 6 7 8 9 10 11 12 13 14 ... 22) Next »
Back to top

In this issue

Advertisement